A detailed history of Verdence Capital Advisors LLC transactions in Vericel Corp stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 6,750 shares of VCEL stock, worth $395,077. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,750
Previous 6,750 -0.0%
Holding current value
$395,077
Previous $309,000 7.77%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

SELL
$29.0 - $38.37 $18,502 - $24,480
-638 Reduced 8.64%
6,750 $253,000
Q1 2023

Apr 24, 2023

BUY
$23.85 - $31.34 $176,203 - $231,539
7,388 New
7,388 $216,000
Q2 2022

Aug 08, 2022

SELL
$22.88 - $39.45 $169,037 - $291,456
-7,388 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$18.53 - $31.5 $166,770 - $283,500
-9,000 Reduced 54.92%
7,388 $228,000
Q4 2017

Jan 30, 2020

BUY
$3.65 - $5.98 $59,816 - $98,000
16,388
16,388 $89,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.